Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3703617011 | Ibalizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3703618018 | Ibalizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ibalizumab | Is a | Antiretroviral | true | Inferred relationship | Some | ||
| Ibalizumab | Has disposition | HIV entry inhibitor | true | Inferred relationship | Some | ||
| Ibalizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Ibalizumab | Is a | Human immunodeficiency virus entry inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ibalizumab-containing product in parenteral dose form | Has active ingredient | True | Ibalizumab | Inferred relationship | Some | 1 |
| Ibalizumab-containing product | Has active ingredient | True | Ibalizumab | Inferred relationship | Some | 1 |
| Ibalizumab only product | Has active ingredient | True | Ibalizumab | Inferred relationship | Some | 1 |
| Ibalizumab only product in parenteral dose form | Has active ingredient | True | Ibalizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR